FIELD: biochemistry.
SUBSTANCE: invention relates to a genetically modified rodent, which expresses on the surface of its T-cells a functional humanised CD3 complex, containing chimeric human/rodent CD3ε proteins, CD3δ and CD3γ, to its cell, as well as to method of its creation. Also disclosed is a method for selecting an antigen-binding protein which induces T-cell activation, comprising administering an antigen of interest in the above genetically modified rodent.
EFFECT: invention enables effective analysis of CD3-based bispecific antigen-binding protein.
57 cl, 11 dwg, 4 tbl, 3 ex
| Title |
Year |
Author |
Number |
| HUMANIZED ANTIBODY TO BCMA AND BCMA-CAR-T CELLS |
2020 |
- Wu, Lijun
- Golubovskaya, Vita
|
RU2762942C1 |
| GENETICALLY MODIFIED ANIMALS OTHER THAN HUMANS FOR PRODUCING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS FOR PRODUCTION AND VERSIONS OF USE THEREOF |
2019 |
|
RU2819525C2 |
| HUMANIZED ANTIBODY TO BCMA AND BCMA-CAR-NK-CELLS |
2020 |
- Wu, Lijun
- Golubovskaya, Vita
|
RU2795443C2 |
| HUMANIZED T-CELL MEDIATED IMMUNE RESPONSES IN NON-HUMAN ANIMALS |
2016 |
- Macdonald, Lynn
- Murphy, Andrew, J.
- Gurer, Cagan
- Kyratsous, Christos
|
RU2732628C2 |
| DITRA MODELS IN NON-HUMAN ANIMALS AND THEIR USE |
2019 |
- Merfi, Endryu Dzh.
- Mudzhika, Aleksander O.
- Lai, Ka-Man Venus
- Khaksinasto, Sokol
- Zarukhi, Khovkhannisyan
|
RU2804448C2 |
| CHIMERIC ANTIGENIC RECEPTORS TO BCMA |
2015 |
- Morgan Richard
- Fridman Kevin
|
RU2747457C2 |
| HLA-NON-RESTRICTED T-CELL RECEPTORS AND THEIR USE |
2019 |
- Sadelain, Michel
- Mansilla-Soto, Jorge, A.
- Eyquem, Justin
- Dobrin, Anton
|
RU2812917C2 |
| ANIMALS OTHER THAN HUMANS HAVING A HUMANISED CLUSTER GENE OF DIFFERENTIATION 47 |
2015 |
- Gurer, Cagan
- Ioffe, Ella
- Mujica, Alexander
- Thurston, Gavin
|
RU2728412C2 |
| IMMUNE CELLS EXPRESSING INVERSE UNIVERSAL CHIMERIC ANTIGEN RECEPTOR, FOR TARGETING VARIOUS MULTIPLE ANTIGENS AND METHOD FOR PRODUCTION AND USE THEREOF FOR TREATING CANCER, INFECTIONS AND AUTOIMMUNE DISEASES |
2019 |
|
RU2824391C2 |
| ANTIBODY TO CD3 AND ITS PHARMACEUTICAL USE |
2019 |
- Ying Hua
- Zhang Ling
- Yang Xiaoying
- Ge Hu
- Tao Weikang
|
RU2802272C2 |
